Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FANCM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NAA40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C18orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM132A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AURKAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALML6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUNX1-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NCOA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF710 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMK2N1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHGB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGSNAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on